Jane C. Moore

Impact of the patient population on the risk for heparin-induced thrombocytopenia

Theodore E. Warkentin, Jo‐Ann I. Sheppard, Peter Horsewood et al. · Blood · 2000 · 912 citations

Quantitative interpretation of optical density measurements using PF4‐dependent enzyme‐immunoassays

Theodore E. Warkentin, Jo‐Ann I. Sheppard, Jane C. Moore et al. · Journal of Thrombosis and Haemostasis · 2008 · 345 citations

Engineering, Biochemistry, Optical Diagnostics +7

Impact of the patient population on the risk for heparin-induced thrombocytopenia

Theodore E. Warkentin, Jo‐Ann I. Sheppard, Peter Horsewood et al. · Blood · 2000 · 313 citations

Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin

Theodore E. Warkentin, Richard J. Cook, Victor J. Marder et al. · Blood · 2005 · 272 citations · Full text

Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: How much class do we need?

Theodore E. Warkentin, Jo‐Ann I. Sheppard, Jane C. Moore et al. · Journal of Laboratory and Clinical Medicine · 2005 · 259 citations

Thrombopoiesis, Thrombosis, Venous Thrombosis +12